Regenerative medicine company Vivex Biologics appointed Chad Kolean as CFO Feb. 12.
Mr. Kolean joins from spinal implant developer Titan Spine, which was acquired by Medtronic last year.
Previously he served as CFO and treasurer for Cellectar Biosciences and Pioneer Surgical Technology, before it merged with RTI Surgical.
Early in his career, Mr. Kolean held several leadership positions within the healthcare and finance sectors, including Tomotherapy, Metavante Corp. and Arthur Andersen.